Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection.
about
Pro-Inflammatory Markers in Relation to Cardiovascular Disease in HIV Infection. A Systematic ReviewInfluence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virusMonocytes as regulators of inflammation and HIV-related comorbidities during cARTA high throughput biochemical fluorometric method for measuring lipid peroxidation in HDLAtherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy.Macrophage inflammatory markers are associated with subclinical carotid artery disease in women with human immunodeficiency virus or hepatitis C virus infectionImmunologic predictors of coronary artery calcium progression in a contemporary HIV cohort.Systemic effects of inflammation on health during chronic HIV infectionIncreased arterial inflammation relates to high-risk coronary plaque morphology in HIV-infected patients.Initiation of antiretroviral therapy at high CD4 cell counts: does it reduce the risk of cardiovascular disease?Microbial translocation and cardiometabolic risk factors in HIV infection.Wellens syndrome in HIV-infected patients: Two case reports.Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection.Inflammation, Immune Activation, and Antiretroviral Therapy in HIVSwitch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial.Can early therapy reduce inflammation?Protease inhibitor monotherapy is associated with a higher level of monocyte activation, bacterial translocation and inflammation.Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment.HIV vasculopathy: role of mononuclear cell-associated Krüppel-like factors 2 and 4.Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women.Soluble CD163 does not predict first-time myocardial infarction in patients infected with human immunodeficiency virus: a nested case-control study.The CD14 C-260T single nucleotide polymorphism (SNP) modulates monocyte/macrophage activation in treated HIV-infected individuals.Cardiovascular disease risk in an aging HIV population: not just a question of biology.The effect of hepatitis C virologic clearance on cardiovascular disease biomarkers in human immunodeficiency virus/hepatitis C virus coinfectionImmune activation markers in peripartum women in Botswana: association with feeding strategy and maternal morbidity.von Willebrand Factor is elevated in HIV patients with a history of thrombosis.Epidemiology and management of antiretroviral-associated cardiovascular disease.Differential levels of soluble inflammatory markers by human immunodeficiency virus controller status and demographics.Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infectionPlaque burden in HIV-infected patients is associated with serum intestinal microbiota-generated trimethylamine.HDL redox activity is increased in HIV-infected men in association with macrophage activation and non-calcified coronary atherosclerotic plaque.Soluble CD14 is a nonspecific marker of monocyte activation.Anaemia is associated with monocyte activation in HIV-infected adults on antiretroviral therapyInterleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral ReservoirDifferential Reduction in Monocyte Activation and Vascular Inflammation With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among HIV-Infected Individuals.Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s.Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial.Elevated Soluble CD14 and Lower D-Dimer Are Associated With Cigarette Smoking and Heavy Episodic Alcohol Use in Persons Living With HIV.Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial
P2860
Q26774828-7CCA3AEF-4734-4885-BE83-E53B1F4A3EB3Q26851535-6451DA99-ED25-4F81-B136-ED12B27D46D4Q27006827-E3E00B16-5DFA-4E39-97C4-4054DC2EC9F9Q28544713-B41AB397-A1EC-441F-9F14-4C8B3BB6FBFAQ30248286-B4D69BB0-FFD5-4669-A102-1771ECCEF506Q30405402-76809B00-0FE6-4722-A898-33FB66B6EECFQ30593046-938D389C-8D81-4E1E-AE08-EC7B2DFB2901Q33577551-F516C951-F02B-44FF-A421-308D0CD89815Q33623429-697699A2-BAC6-4C89-AD43-B91DA722BE82Q33649200-1C8C93BC-F381-4D24-B5C4-ED5FC01200ECQ33713895-3508400E-DA61-4B46-9688-32B7FE318D96Q33818111-AB85AD6F-EE17-4D64-B9CE-CC532A898828Q33827624-0A6BA21C-F76E-4895-8A9D-7CB0A441726EQ33899641-3558E4B6-E654-4222-A228-328C38544284Q33912595-71FBE477-1D2C-4EE8-AC3D-BA0B9740E6A6Q33934080-3803E28C-57F6-4039-9853-3DA6FCA65A2BQ34159822-A044B7F1-5D6B-48F8-BEFF-13CC877ADC3AQ34288534-15E56858-D1C9-4134-9632-27372FBA9316Q34315579-483BB5AF-8ED3-4F91-86A2-AA54545DD384Q34494208-5F492FCA-620B-4D22-9214-6F32110DF671Q34568436-7B909105-2D72-4A13-BDF4-E23481AA6439Q34732822-0312A39A-B065-490E-ABA5-C364000C4044Q35030351-847DBD57-DFEE-4591-9D6A-04383940F693Q35064091-BAEF07CB-B15E-4577-9EE6-F4B6D60B1D58Q35072020-CFAFD1DA-4DBA-49F8-A1A8-AC022C06FC1AQ35127830-BB566DEB-D165-4D64-A4DB-3DFE838AD45CQ35166840-B191F9FE-648A-48FE-B663-6920A2C2BF3EQ35338096-24A00708-7D65-4F1D-AF6D-5FD0A13F4B84Q35408098-7396475C-9FFE-44A6-A446-2B6D53EBDBDEQ35473503-75689F21-9B32-4B10-AFAA-D1950D21E6B8Q35538941-6B86A1B1-F8A4-4B77-A12B-2362838F3BB9Q35579905-037AACE6-6C9E-4C64-9A93-90EB48559E65Q35676127-68099C1C-687C-42EC-ADE5-82EBDF8C6ECEQ35935289-7986512C-02CB-4FF5-9B30-1ECA96058A34Q35946786-4264EACA-638F-4D4E-B6BE-AE55F9E40C92Q35965242-B55884BE-065F-4DDD-A367-54BFE5EDFBC2Q35974422-1150EE5D-C3A0-46CB-ADF8-F9A56335126FQ36170370-ED479EAB-9758-439F-992A-CD474DEB8052Q36220304-62F255ED-919C-4BE1-835F-66FA3216CFA9Q36339858-6BD1343A-672B-4072-A1ED-9FA5CD90D49D
P2860
Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Biomarkers of microbial transl ...... osclerosis in HIV-1 infection.
@ast
Biomarkers of microbial transl ...... osclerosis in HIV-1 infection.
@en
type
label
Biomarkers of microbial transl ...... osclerosis in HIV-1 infection.
@ast
Biomarkers of microbial transl ...... osclerosis in HIV-1 infection.
@en
prefLabel
Biomarkers of microbial transl ...... osclerosis in HIV-1 infection.
@ast
Biomarkers of microbial transl ...... osclerosis in HIV-1 infection.
@en
P2093
P2860
P921
P356
P1476
Biomarkers of microbial transl ...... osclerosis in HIV-1 infection.
@en
P2093
Howard N Hodis
Judith S Currier
Michelle A Kendall
Otto O Yang
P2860
P304
P356
10.1093/INFDIS/JIS545
P407
P577
2012-10-12T00:00:00Z